Pregnancy complicated by adenomyosis resulted in miscarriage in three cases of in vitro fertilization-embryo transfer

Three women with adenomyosis conceived by in vitro fertilization-embryo transfer (IVF-ET), but miscarried in the second trimester. The uterus in each case was inflamed post-partum and one patient underwent total abdominal hysterectomy as treatment for the severe inflammation. Although the mechanism of the miscarriages is unclear, these cases strongly suggest that it is related to the inflammation of the myometrium associated with adenomyosis, and that such pregnancies have a high risk of not continuing to term. Preventing inflammation could result in a live birth.

[1]  Y. Soong,et al.  Effect of a Sonographically Diffusely Enlarged Uterus Without Distinct Uterine Masses on the Outcome of In Vitro Fertilization–Embryo Transfer , 1999, Journal of Assisted Reproduction and Genetics.

[2]  G. Matarese,et al.  Pathogenesis of endometriosis: natural immunity dysfunction or autoimmune disease? , 2003, Trends in molecular medicine.

[3]  D. Timmerman,et al.  Uterine adenomyosis in the infertility clinic. , 2003, Human reproduction update.

[4]  日本不妊学会,et al.  Reproductive medicine and biology , 2002 .

[5]  W. Nothnick Treating endometriosis as an autoimmune disease. , 2001, Fertility and sterility.

[6]  Y. Ville [Premature delivery and inflammation]. , 2001, Journal de gynecologie, obstetrique et biologie de la reproduction.

[7]  Y. Abe,et al.  Novel conservative medical therapy for uterine adenomyosis with a danazol-loaded intrauterine device. , 2000, Fertility and sterility.

[8]  K. Shimoya,et al.  Cytokine production in chorioamnionitis. , 2000, Journal of reproductive immunology.

[9]  H. Zheng,et al.  Gonadotropin-releasing hormone agonists and laparoscopy in the treatment of adenomyosis with infertility. , 2000, Chinese medical journal.

[10]  H. Chao,et al.  Treatment of infertile women with adenomyosis with a conservative microsurgical technique and a gonadotropin-releasing hormone agonist. , 2000, Fertility and sterility.

[11]  F. Kung,et al.  Effects of short-course buserelin therapy on adenomyosis. A report of two cases. , 1999, The Journal of reproductive medicine.

[12]  J. Hatazawa,et al.  Is adenomyosis an immune disease? , 1998, Human reproduction update.

[13]  C. Reinhold,et al.  Imaging features of adenomyosis. , 1998, Human reproduction update.

[14]  C. Yuan,et al.  Successful pregnancy after treatment of deep adenomyosis with cytoreductive surgery and subsequent gonadotropin-releasing hormone agonist: a case report. , 1998, Zhonghua yi xue za zhi = Chinese medical journal; Free China ed.

[15]  J. Mok,et al.  Simplified ultralong protocol of gonadotrophin-releasing hormone agonist for ovulation induction with intrauterine insemination in patients with endometriosis. , 1996, Human reproduction.

[16]  J. Halme Release of tumor necrosis factor-α by human peritoneal macrophages in vivo and in vitro , 1989 .

[17]  J. Halme Release of tumor necrosis factor-alpha by human peritoneal macrophages in vivo and in vitro. , 1989, American journal of obstetrics and gynecology.

[18]  J. Lee,et al.  Interleukin-1: a possible role in the infertility associated with endometriosis. , 1987, Fertility and sterility.

[19]  R. Kistner,et al.  Revised American Fertility Society classification of endometriosis: 1985. , 1985, Fertility and sterility.

[20]  J. Weinberg,et al.  Peritoneal fluid cell populations in infertility patients. , 1981, Fertility and sterility.